Trade Straumann Holding AG - STMN CFD
Add to favourite- Summary
- Historical Data
- Events
- Income Statement
- Balance Sheet
Spread | 3.25 | ||||||||
Long position overnight fee
Long position overnight fee
Go to platform | -0.014983% | ||||||||
Short position overnight fee
Short position overnight fee
Go to platform | -0.007239% | ||||||||
Overnight fee time | 21:00 (UTC) | ||||||||
Min traded quantity | 0.1 | ||||||||
Currency | CHF | ||||||||
Margin | 5% | ||||||||
Stock exchange | Switzerland | ||||||||
Commission on trade | 0% |
*Information provided by Capital.com
Prev. Close* | 133.5 |
Open* | 131 |
1-Year Change* | -6.6% |
Day's Range* | 131 - 133.5 |
52 wk Range | 97.00-147.00 |
Average Volume (10 days) | 182.37K |
Average Volume (3 months) | 5.17M |
Market Cap | 20.79B |
P/E Ratio | 55.50 |
Shares Outstanding | 159.36M |
Revenue | 2.36B |
EPS | 2.35 |
Dividend (Yield %) | 0.6135 |
Beta | 1.42 |
Next Earnings Date | Feb 19, 2024 |
All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Close | Change | Change (%) | Open | High | Low |
---|---|---|---|---|---|---|
Apr 18, 2024 | 133.50 | -0.75 | -0.56% | 134.25 | 134.25 | 131.25 |
Apr 17, 2024 | 134.50 | 0.00 | 0.00% | 134.50 | 136.25 | 133.75 |
Apr 16, 2024 | 136.00 | -0.50 | -0.37% | 136.50 | 136.50 | 133.50 |
Apr 15, 2024 | 139.50 | 1.25 | 0.90% | 138.25 | 141.50 | 136.25 |
Apr 12, 2024 | 136.50 | -5.75 | -4.04% | 142.25 | 143.00 | 136.50 |
Apr 11, 2024 | 140.75 | 1.25 | 0.90% | 139.50 | 142.50 | 138.25 |
Apr 10, 2024 | 140.25 | -3.25 | -2.26% | 143.50 | 144.50 | 136.25 |
Apr 9, 2024 | 142.50 | 3.50 | 2.52% | 139.00 | 143.00 | 139.00 |
Apr 8, 2024 | 140.25 | 1.25 | 0.90% | 139.00 | 141.75 | 138.75 |
Apr 5, 2024 | 139.00 | 2.25 | 1.65% | 136.75 | 139.25 | 136.00 |
Apr 4, 2024 | 139.75 | -0.25 | -0.18% | 140.00 | 140.25 | 137.50 |
Apr 3, 2024 | 139.50 | 0.50 | 0.36% | 139.00 | 140.25 | 137.00 |
Apr 2, 2024 | 139.50 | -3.25 | -2.28% | 142.75 | 142.75 | 138.25 |
Mar 28, 2024 | 142.00 | -1.50 | -1.05% | 143.50 | 145.00 | 141.25 |
Mar 27, 2024 | 141.75 | -2.00 | -1.39% | 143.75 | 144.75 | 141.25 |
Mar 26, 2024 | 141.50 | 3.00 | 2.17% | 138.50 | 142.50 | 138.50 |
Mar 25, 2024 | 137.50 | -3.25 | -2.31% | 140.75 | 140.75 | 136.75 |
Mar 22, 2024 | 141.75 | -4.00 | -2.74% | 145.75 | 146.75 | 141.00 |
Mar 21, 2024 | 145.25 | -0.25 | -0.17% | 145.50 | 147.75 | 144.50 |
Mar 20, 2024 | 142.50 | 3.75 | 2.70% | 138.75 | 143.50 | 138.75 |
Straumann Holding AG Events
Time (UTC) | Country | Event |
---|---|---|
Tuesday, April 30, 2024 | ||
Time (UTC) 05:00 | Country CH
| Event Q1 2024 Straumann Holding AG Corporate Sales Release Q1 2024 Straumann Holding AG Corporate Sales ReleaseForecast -Previous - |
Tuesday, June 4, 2024 | ||
Time (UTC) 10:59 | Country CH
| Event Straumann Holding AG at Exane BNPP CEO Conference Straumann Holding AG at Exane BNPP CEO ConferenceForecast -Previous - |
- Annual
- Quarterly
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Total revenue | 2320.78 | 2021.9 | 1425.85 | 1596.22 | 1363.56 |
Revenue | 2320.78 | 2021.9 | 1425.85 | 1596.22 | 1363.56 |
Cost of Revenue, Total | 564.746 | 481.88 | 387.544 | 391.477 | 335.315 |
Gross Profit | 1756.04 | 1540.02 | 1038.31 | 1204.75 | 1028.24 |
Total Operating Expense | 1785.44 | 1480.2 | 1279.91 | 1202.98 | 1017.52 |
Selling/General/Admin. Expenses, Total | 1158.47 | 992.898 | 718.686 | 797.848 | 680.034 |
Unusual Expense (Income) | 13.751 | -0.38 | 166.416 | 18.715 | 5.59 |
Other Operating Expenses, Total | -4.856 | -4.813 | -4.592 | -5.063 | -3.424 |
Operating Income | 535.35 | 541.701 | 145.942 | 393.248 | 346.045 |
Interest Income (Expense), Net Non-Operating | -36.75 | -64.224 | -31.899 | -27.357 | -19.343 |
Other, Net | -0.165 | -0.092 | -0.136 | -0.422 | -0.276 |
Net Income Before Taxes | 498.435 | 477.385 | 113.907 | 365.469 | 326.426 |
Net Income After Taxes | 434.78 | 399.286 | 92.267 | 308.029 | 277.787 |
Minority Interest | 0.009 | -3.206 | -0.986 | -1.556 | -5.017 |
Net Income Before Extra. Items | 434.789 | 396.08 | 91.281 | 306.473 | 272.77 |
Net Income | 434.789 | 396.08 | 91.281 | 306.473 | 272.77 |
Total Adjustments to Net Income | -0.001 | 0.001 | |||
Income Available to Common Excl. Extra. Items | 434.789 | 396.079 | 91.282 | 306.473 | 272.77 |
Income Available to Common Incl. Extra. Items | 434.789 | 396.079 | 91.282 | 306.473 | 272.77 |
Diluted Net Income | 434.789 | 396.079 | 91.282 | 306.473 | 272.77 |
Diluted Weighted Average Shares | 159.572 | 159.592 | 159.248 | 159.136 | 158.809 |
Diluted EPS Excluding Extraordinary Items | 2.72473 | 2.48182 | 0.57321 | 1.92585 | 1.7176 |
Dividends per Share - Common Stock Primary Issue | 0.8 | 0.675 | 0.575 | 0.575 | 0.525 |
Diluted Normalized EPS | 2.82064 | 2.51461 | 2.27359 | 2.02497 | 1.74755 |
Depreciation / Amortization | 53.321 | 10.617 | 11.855 |
Jun 2023 | Dec 2022 | Jun 2022 | |
---|---|---|---|
Total revenue | 1216.89 | 1142.45 | 1178.34 |
Revenue | 1216.89 | 1142.45 | 1178.34 |
Cost of Revenue, Total | 301.636 | 283.372 | 282.677 |
Gross Profit | 915.252 | 859.074 | 895.662 |
Total Operating Expense | 920.304 | 930.992 | 854.443 |
Selling/General/Admin. Expenses, Total | 602.445 | 650.773 | 573.469 |
Other Operating Expenses, Total | -3.873 | -3.153 | -1.703 |
Operating Income | 296.584 | 211.454 | 323.896 |
Interest Income (Expense), Net Non-Operating | -41.091 | -28.708 | -8.207 |
Net Income Before Taxes | 255.493 | 182.746 | 315.689 |
Net Income After Taxes | 209.615 | 169.514 | 265.266 |
Minority Interest | -0.243 | -0.128 | 0.137 |
Net Income Before Extra. Items | 209.372 | 169.386 | 265.403 |
Net Income | 205.776 | 169.386 | 265.403 |
Income Available to Common Excl. Extra. Items | 209.372 | 169.386 | 265.403 |
Income Available to Common Incl. Extra. Items | 205.776 | 169.386 | 265.403 |
Diluted Net Income | 205.776 | 169.386 | 265.403 |
Diluted Weighted Average Shares | 159.627 | 159.705 | 159.881 |
Diluted EPS Excluding Extraordinary Items | 1.31163 | 1.06062 | 1.66 |
Dividends per Share - Common Stock Primary Issue | 0 | 0.8 | 0 |
Diluted Normalized EPS | 1.39329 | 1.06062 | 1.66 |
Depreciation / Amortization | 4.208 | ||
Unusual Expense (Income) | 15.888 | ||
Total Extraordinary Items | -3.596 |
- Annual
- Quarterly
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Total Current Assets | 1593.21 | 1528.67 | 1152.25 | 881.665 | 765.031 |
Cash and Short Term Investments | 696.102 | 880.423 | 632.201 | 260.211 | 278.674 |
Cash | 381.133 | 743.669 | 508.713 | 249.673 | 268.252 |
Short Term Investments | 314.969 | 136.754 | 123.488 | 10.539 | 10.422 |
Total Receivables, Net | 570.123 | 393.806 | 301.183 | 380.961 | 300.286 |
Accounts Receivable - Trade, Net | 416.366 | 287.269 | 236.027 | 281.21 | 231.301 |
Total Inventory | 321.172 | 249.227 | 216.57 | 234.553 | 182.053 |
Prepaid Expenses | 4.808 | 4.141 | 2.009 | 4.361 | 2.939 |
Other Current Assets, Total | 1.01 | 1.075 | 0.289 | 1.579 | 1.079 |
Total Assets | 3373.44 | 2968.04 | 2548.61 | 2389.98 | 1864.57 |
Property/Plant/Equipment, Total - Net | 663.493 | 578.87 | 549.131 | 575.748 | 230.206 |
Property/Plant/Equipment, Total - Gross | 1191.07 | 1044.49 | 977.781 | 953.788 | 568.038 |
Accumulated Depreciation, Total | -527.58 | -465.62 | -428.65 | -378.039 | -337.831 |
Goodwill, Net | 524.311 | 425.35 | 424.258 | 484.628 | 417.286 |
Intangibles, Net | 253.639 | 213.537 | 226.027 | 258.213 | 235.157 |
Long Term Investments | 207.29 | 119.486 | 103.528 | 100.701 | 119.515 |
Note Receivable - Long Term | 25.685 | 25.297 | 17.415 | 28.68 | 26.957 |
Other Long Term Assets, Total | 105.802 | 76.826 | 76.002 | 60.343 | 70.417 |
Total Current Liabilities | 972.104 | 562.628 | 379.42 | 578.983 | 274.35 |
Accounts Payable | 83.229 | 74.832 | 49.919 | 63.207 | 47.557 |
Accrued Expenses | 173.882 | 160.273 | 105.171 | 136.778 | 94.178 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Port. of LT Debt/Capital Leases | 306.608 | 25.846 | 25.934 | 223.859 | 0.72 |
Other Current Liabilities, Total | 408.386 | 301.678 | 198.396 | 155.139 | 131.896 |
Total Liabilities | 1521.84 | 1472.64 | 1343.88 | 1026.56 | 663.645 |
Total Long Term Debt | 394.988 | 680.723 | 696.113 | 231.642 | 201.191 |
Long Term Debt | 199.901 | 479.841 | 479.726 | 0 | 199.862 |
Capital Lease Obligations | 195.087 | 200.882 | 216.387 | 231.642 | 1.329 |
Deferred Income Tax | 52.696 | 31.04 | 43.228 | 36.887 | 36.211 |
Minority Interest | 2.247 | 5.048 | 5.209 | 3.809 | 3.396 |
Other Liabilities, Total | 99.802 | 193.199 | 219.909 | 175.244 | 148.497 |
Total Equity | 1851.6 | 1495.4 | 1204.73 | 1363.41 | 1200.92 |
Common Stock | 1.595 | 1.592 | 1.591 | 1.588 | 1.588 |
Additional Paid-In Capital | 102.012 | 70.567 | 52.599 | 31.412 | 31.412 |
Retained Earnings (Accumulated Deficit) | 2223.18 | 1843.82 | 1536.49 | 1556.27 | 1356.84 |
Treasury Stock - Common | -11.08 | -5.462 | -11.07 | -9.361 | -19.87 |
Other Equity, Total | -464.107 | -415.118 | -374.876 | -216.498 | -169.045 |
Total Liabilities & Shareholders’ Equity | 3373.44 | 2968.04 | 2548.61 | 2389.98 | 1864.57 |
Total Common Shares Outstanding | 159.355 | 159.157 | 158.92 | 158.655 | 158.334 |
Payable/Accrued | -0.001 | -0.001 | -0.001 | ||
Cash & Equivalents | -0.001 |
Jun 2023 | Dec 2022 | Jun 2022 | |
---|---|---|---|
Total Current Assets | 1588.46 | 1593.21 | 1544.73 |
Cash and Short Term Investments | 606.157 | 698.961 | 737.649 |
Cash & Equivalents | 603.125 | 696.103 | 734.801 |
Short Term Investments | 3.032 | 2.858 | 2.848 |
Total Receivables, Net | 622.483 | 573.082 | 510.712 |
Accounts Receivable - Trade, Net | 594.01 | 544.842 | 495.182 |
Total Inventory | 359.819 | 321.172 | 296.371 |
Other Current Assets, Total | 0.001 | ||
Total Assets | 3425.2 | 3373.44 | 3186.72 |
Property/Plant/Equipment, Total - Net | 684.114 | 663.493 | 637.657 |
Intangibles, Net | 815.94 | 777.95 | 701.761 |
Long Term Investments | 198.786 | 212.475 | 185.528 |
Note Receivable - Long Term | 25.295 | 21.402 | 17.491 |
Other Long Term Assets, Total | 112.605 | 104.9 | 99.553 |
Total Current Liabilities | 956.043 | 972.104 | 543.636 |
Payable/Accrued | 568.276 | 574.107 | 449.707 |
Notes Payable/Short Term Debt | 0 | 0 | 0 |
Current Port. of LT Debt/Capital Leases | 306.839 | 307.198 | 28.641 |
Other Current Liabilities, Total | 80.928 | 90.799 | 65.288 |
Total Liabilities | 1531.18 | 1521.84 | 1438.84 |
Total Long Term Debt | 399.851 | 403.117 | 696.764 |
Long Term Debt | 399.851 | 403.117 | 696.764 |
Deferred Income Tax | 48.284 | 52.696 | 59.532 |
Minority Interest | 2.158 | 2.247 | 2.35 |
Other Liabilities, Total | 124.845 | 91.673 | 136.554 |
Total Equity | 1894.02 | 1851.6 | 1747.89 |
Common Stock | 1.595 | 1.595 | 1.594 |
Additional Paid-In Capital | 102.012 | 102.012 | 102.012 |
Retained Earnings (Accumulated Deficit) | 2283.48 | 2223.18 | 2050.01 |
Treasury Stock - Common | -13.929 | -11.08 | -7.93 |
Other Equity, Total | -479.141 | -464.107 | -397.798 |
Total Liabilities & Shareholders’ Equity | 3425.2 | 3373.44 | 3186.72 |
Total Common Shares Outstanding | 159.355 | 159.355 | 159.157 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Straumann Company profile
About Straumann Holding AG
Straumann Holding AG is a Switzerland-based company active in the field of implant and restorative dentistry and oral tissue regeneration. In collaboration with clinics, research institutes and universities, the Group researches and develops implants, instruments, computer-aided design/manufacturing (CAD/CAM) prosthetics and tissue regeneration products for use in tooth replacement and restoration solutions or to prevent tooth loss. Straumann Holding AG also offers a range of services to the dental profession worldwide, including training and education, provided in collaboration with the International Team for Implantology (ITI). Its products and services are available in a number of countries through the Group’s headquarters and through a network of subsidiaries and technology partners located in Europe, North America, the Asia/Pacific region and in Latin America, including Dental Wings Inc based in Canada and Createch Medical SL based in Spain.
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, Straumann Holding AG revenues increased 42% to SF2.02B. Net income applicable to common stockholders increased from SF91.3M to SF396.1M. Revenues reflect Sales NAM segment increase of 39% to SF613.6M, Sales APAC segment increase of 39% to SF388.8M, Sales LATAM segment increase of 44% to SF129.7M, Others segment increase of 35% to SF666.9M, United States segment increase of 30% to SF516.9M.
Industry: | Medical Prosthetics |
Peter Merian-Weg 12
BASEL
BASEL-STADT 4002
CH
Income Statement
- Annual
- Quarterly
News
Gold price in 2024: geopolitical tensions and rate-cut expectations keep XAU/USD supported
Investors are keeping a close eye on gold as the conflict in the Middle East escalates with a possibility of a full-scale regional war in the area.
07:56, 17 April 2024US Earnings Season : JP Morgan, Citigroup, Wells Fargo
The first major US banks report quarterly earnings on Friday, April 12th, 2024. We preview what to expect from JP Morgan, Citigroup, and Wells Fargo's quarterly numbers.
16:03, 11 April 2024Reserve Bank of New Zealand Preview: Rates expected to remain on hold as inflation fight continues
The Reserve Bank of New Zealand (RBNZ) meets on Wednesday, April 10, 2024. We preview what to expect from the meeting and its possible impact on the NZD/USD.
09:22, 11 April 2024US CPI Preview: US inflation expected to grind lower amid fears about sticky prices
US CPI data is released on Wednesday, 10 April. We preview what to expect from the data, how it could influence US Federal Reserve policy, and analyse the NASDAQ (US Tech 100).
15:11, 9 April 2024How escalating geopolitical tensions are impacting oil markets
The bullish momentum in oil prices remains strong as escalating geopolitical tensions raise concerns about supply.
13:34, 4 April 2024A way forward: a roundup of recent central bank decisions
Five of the world’s most significant central banks delivered policy this week. We review the decisions and discuss their impact on the markets.
12:47, 22 March 2024Bank of Japan Preview: will the BOJ end negative interest rates?
The Bank of Japan meets on Tuesday 19th of March. We preview what to expect from the BOJ decision and how it might impact the USD/JPY and Nikkei 225.
08:44, 18 March 2024People also watch
Still looking for a broker you can trust?
Join the 610,000+ traders worldwide that chose to trade with Capital.com